Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -10.215% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl
b. CCN(CC)C(=O)N1c2ccccc2C=Cc2ccccc21
c. CC/C(C)=N/Nc1nc(-c2cc3cccc(OC)c3oc2=O)cs1
Answer: b. CCN(CC)C(=O)N1c2ccccc2C=Cc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)C(=O)N1c2ccccc2C=Cc2ccccc21
CCN(CC)C(=O)N1c2ccccc2C=Cc2ccccc21
N,N-diethyl-2-azatricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide